FINWIRES · TerminalLIVE
FINWIRES

Correction: Calian Group Up 11% On Improved Q2 Net Profit, Revenue

By

(Correcting second paragraph to show the results were "For Q2". A corrected version follows)

Calian Group (CGY.TO) was at last look up 11% in early Thursday trade after reporting higher net profit and revenue in the second quarter as the company begins to "capture the benefits of strengthening demand across the defence sector".

For Q2, net profit was C$6.7 million, or $0.58 per diluted share, compared to $0.3 million, or $0.02 per diluted share in the corresponding year-ago quarter. The increase is primarily related to higher adjusted EBITDA and lower mergers and acquisition costs, partially offset by higher restructuring expenses and taxes, said the company.

Second quarter adjusted net profit was $15.1 million, or $1.30 per diluted share, up from $9.1 million, or $0.77 per diluted share, in the year-ago quarter.

Second quarter revenue was a record $228.7 million, compared to $193.7 million in the year-ago quarter. The consensus estimates compiled by FactSet for Sales was $215.7 million.

Acquisitive growth was 6% and was generated by the acquisitions of Advanced Medical Solutions completed in May 2025 and Infield Scientific closed in October 2025. Organic growth was 12% and was generated by both the Defence & Space and Essential Industries segments.

On May 13, 2026, the company declared a quarterly dividend of $0.28 per share, unchanged from the prior quarter. The dividend is payable June 10, 2026, to shareholders of record as of May 27, 2026.

"Our second quarter results mark an important inflection point for Calian as we begin to capture the benefits of strengthening demand across the defence sector," said Patrick Houston, Calian Chief Executive Officer.

He added: "Revenue grew 18%, including 12% organic growth, which was achieved through record-setting deliveries and a strong pace of contract signings. This solid top-line performance translated into an 60% increase in adjusted EBITDA, which significantly outpaced revenue growth and reflects the compounded impact of higher volumes and improved operational leverage.

"These results reflect early but tangible momentum in government defence spending and validate the strategic choices we have made to sharpen our operating model. With a $1.5 billion backlog, a robust acquisition pipeline, and a solid balance sheet, we are well-positioned to capture market share, deliver strong full year performance, and create lasting value for shareholders."

Price: $75.90, Change: $+7.90, Percent Change: +11.62%

Related Articles

Mining & Metals

CIBC Raises Hydro One's Price Target to C$59.00 Following the Company's Q1 Results

CIBC Capital Markets reiterated its neutral rating on the shares of Hydro One (H.TO) while bumping its price target to C$59.00 from $58.00 following the company's first-quarter results.Hydro One's results reinforce the company's strong positioning, with earnings momentum tracking toward the upper end of its 6%-8% medium-term earnings per share growth target, CIBC said.The company recorded an uptick in near-term distribution capex, and the medium-term to longer-term investment outlook remains strong buoyed by many transmission projects, according to CIBC.Price: $59.17, Change: $+0.40, Percent Change: +0.68%

$H.TO
Mining & Metals

Manulife Financial Price Target Raised to $59.00 at National Bank

National Bank raised its price target on the shares of Manulife Financial (MFC.TO, MFC) by C$2.00 to C$59.00 and maintained its outperform rating even though the insurer reported a first-quarter core earnings miss.Manulife's first-quarter core EPS of $1.06, missed analyst Gabriel Dechaine's forecast of $1.08 and consensus of $1.10.The lifeco's U.S. segment, which reported $250 million of mortality experience losses in 2025, turned positive this quarter (as did LTC morbidity).Asia region earnings were up 22%. Aside from the segment's expected contribution to the 2027 ROE target, Dechaine notes that investors focus on sales growth as an indicator of profit growth beyond 2027. To that end, insurance sales were up 8%, including 18% growth in Hong Kong, addressing concerns that regulatory changes would hamper sales performance for an extended period, he writes.Manulfe reported $38 million of experience losses in Canada, driven by higher disability claims in the Group business. Global wealth and asset management (WAM) earnings were slightly below expectations, as net outflows were larger than expected at $4.4 billion.Price: $51.59, Change: $-3.04, Percent Change: -5.56%

$MFC$MFC.TO
Mining & Metals

CIBC Initiates Coverage of MDA Space with Outperformer Rating and C$57.00 Price Target

CIBC Capital Markets initiated coverage of MDA Space (MDA.TO) with an outperformer rating and C$57.00 price target..CIBC views MDA Space as a "compelling pure-play on the rapidly expanding space economy.""We are initiating coverage of MDA Space with an Outperformer rating and $57.00 price target, applying a 21x EV/EBITDA multiple on 2027E," said CIBC.CIBC's investment thesis rests on "three core pillars", which are, the company's unique exposure to multiple secular tailwinds driving the space boom; its status as a scaled, well-capitalized and profitable pure-play amid an industry of mostly unprofitable peers; and a valuation that is undemanding relative to both A&D peers and space-sector peers, CIBC stated."Key near-term catalysts are tied to funded programs, reinforcing our confidence in the company's trajectory," said CIBC.According to CIBC, MDA's robust pipeline, profitability, and net cash position set it apart from legacy A&D players with limited growth and from newer space entrants that lack earnings."We value MDA at 21x F2027E EBITDA, in line with higher-growth, profitable SMID-cap A&D peers, and we see further upside potential as the company executes on its pipeline," added CIBC. "Should MDA win an incremental 5% share of the LEO market over the next two years, we see upside of 5% and 14% to our 2026 and 2027 revenue estimates, respectively, translating to an implied equity value of ~$65/share."Price: $53.12, Change: $+0.63, Percent Change: +1.20%

$MDA.TO